Continued use of statins was associated with a 25 percent reduced risk of major adverse cardiovascular events in patients after carotid revascularization, according to a Canadian study with five years of follow-up. But only about two-thirds of patients were taking moderate to high doses of the drugs prior to their procedures.

Research in the Journal of the Journal of the American Heart Association suggests sleeping beyond the recommended seven to eight hours a night can increase the risk of cardiovascular disease (CVD) and death. 

Researchers from the Cleveland Clinic have developed what could become a new class of cardiovascular drugs—one that lowers platelet responsiveness and excessive clot formation by targeting a specific bacteria byproduct in the gut.

A 13-gene signature can separate Kawasaki disease from other febrile and inflammatory conditions, potentially opening the door to blood tests that allow quicker treatment and the prevention of coronary artery aneurysms.

Atrial fibrillation (AFib) and atrial flutter (AFL) are often regarded as interchangeable when informing the management of stroke risk. However, a new study in JAMA Network Open suggests clinical outcomes are worse for patients with AFib, even if they have the same values on the standard CHA2DS2-VASc scoring system.

Smoking hookah for 30 minutes causes changes in arterial stiffness similar to what’s seen after someone smokes a cigarette, according to a study published in the American Journal of Cardiology.

Researchers with LSU Health New Orleans School of Medicine believe they’ve discovered a molecular explanation for why hypoxia increases the risk for blood clots.

Rapid Medical has received CE mark approval for its Tigertriever 13 clot retriever, the smallest such device on the market which is designed to treat intracranial vessels between one and 2.5 millimeters.